Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Tables)

v3.21.1
Stockholders' Deficit (Tables)
9 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Stock Warrant Activity

Warrant detail for the nine months ended March 31, 2021 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2020     83,205     $ 4.00       2.01  
Warrants issued     185,955     $ 4.80       5.00  
Warrants exercised     (32,977 )   $ 4.80          
Warrants forfeited     (11,700 )   $ 4.80       -  
Warrants outstanding and exercisable at March 31, 2021     224,483     $ 4.50       3.22  

 

Warrant detail for the nine months ended March 31, 2020 is reflected below:

 

    Number of Warrants     Weighted Average Exercise Price Per Warrant     Remaining Contract Term (# years)  
Warrants outstanding and exercisable at June 30, 2019     8,333     $ 20.00       0.25  
Warrants forfeited     (8,333 )   $ 20.00       -  
Warrants outstanding and exercisable at March 31, 2020     -       $          
Schedule of Stock Options Activity

Activity in stock options during the nine months ended March 31, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     579,584     $ 11.00       7.55  
Exercised     (15,812 )   $ 5.77       -  
Forfeited and cancelled     (18,932 )   $ 12.45       -  
Outstanding at March 31, 2021     544,840     $ 11.10       6.81  
Exercisable at March 31, 2021     490,493     $ 10.91       6.67  

  

Activity in stock options during the nine months ended March 31, 2020 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Exercise Price    

Weighted Average Remaining

Contract Term

(# years)

 
Outstanding at June 30, 2019     580,171     $ 11.05       8.59  
Granted     15,792     $ 8.87       -  
Exercised     (5,249 )   $ 4.68       -  
Forfeited and cancelled     (8,718 )   $ 12.56       -  
Outstanding at March 31, 2020     581,996     $ 11.02       7.87  
Exercisable at March 31, 2020     414,720     $ 10.65       7.53
Schedule of Restricted Stock Units Activity

Activity in RSUs during the nine months ended March 31, 2021 and related balances outstanding as of that date are reflected below:

 

    Number of Shares     Weighted Average Grant date Fair Value    

Weighted Average Remaining Contract Term

(# years)

 
Outstanding at June 30, 2020     -     $ -       -  
Granted     134,865     $ 8.88       -  
Forfeited and cancelled     (6,542 )   $ 8.88       -  
Outstanding at March 31, 2021     128,323     $ 8.88       2.91  
Schedule of Stock-Based Compensation Expenses

The following table summarizes stock-based compensation expense for employee and non-employee option grants and RSUs:

 

    Three Months Ended
March 31,
    Nine Months Ended
March 31,
 
    2021     2020     2021     2020  
Research and development   $ 48,000     $ 54,000     $ 146,000     $ 162,000  
Selling and administrative     180,000       402,000       504,000       1,194,000  
Total stock-based compensation expense   $ 228,000     $ 456,000     $ 650,000     $ 1,356,000
Schedule of Fair Value Assumptions of Stock Options

The Company uses the Black-Scholes valuation model to calculate the fair value of stock options. The fair value of stock options was measured at the grant date using the assumptions (annualized percentages) in the table below:

 

    Nine Months Ended
March 31,
 
    2021     2020  
Expected volatility     0 %     100.60 %
Risk free interest rate     0 %     1.73 %
Forfeiture rate     20 %     20 %
Dividend yield     0 %     0 %
Expected term (years)     0       5.56